首页> 外文期刊>Forensic toxicology >A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N-OH-EDMA, and a cathinone derivative dimethoxy-alpha-PHP, newly identified in illegal products
【24h】

A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N-OH-EDMA, and a cathinone derivative dimethoxy-alpha-PHP, newly identified in illegal products

机译:合成大麻素FDU-NNEI,合成大麻素AB-CHMINACA和NNEI吲唑类似物(MN-18)的两个2H-吲唑异构体,苯乙胺衍生物N-OH-EDMA和卡西酮衍生物二甲氧基-α-PHP非法产品

获取原文
获取原文并翻译 | 示例
           

摘要

Six new psychoactive substances were identified together with two other substances (compounds 1-8) in illegal products by our ongoing survey in Japan between January and July 2014. A new synthetic cannabinoid, FDU-NNEI [1-(4-fluorobenzyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide, 2], was detected with the newly distributed synthetic cannabinoid FDU-PB-22 (1). Two 2H-indazole isomers of synthetic cannabinoids, AB-CHMINACA 2H-indazole analog (3) and NNEI 2H-indazole analog (4), were newly identified with 1H-indazoles [AB-CHMINACA and NNEI indazole analog (MN-18)]. In addition, 2-methylpropyl N-(naphthalen-1-yl) carbamate (5) and isobutyl 1-pentyl-1H-indazole-3-carboxylate (6) were detected in illegal products. Compound 6 is considered to be a by-product of the preparation of NNEI indazole analog from compound 5 and 1-pentyl-1H-indazole. A phenethylamine derivative, N-OH-EDMA [N-hydroxy-3,4-ethylenedioxy-N-methylamphetamine, 7], and a cathinone derivative, dimethoxy-alpha-PHP (dimethoxy-alpha-pyrrolidinohexanophenone, 8), were newly identified in illegal products. Among them, compounds 1 and 8 have been controlled as designated substances (Shitei-Yakubutsu) under the Pharmaceutical Affairs Law in Japan since August and November 2014, respectively.
机译:我们在2014年1月至7月间在日本进行的持续调查中,在非法产品中鉴定出六种新的精神活性物质以及其他两种物质(化合物1-8)。一种新的合成大麻素FDU-NNEI [1-(4-氟苄基)-N用新分布的合成大麻素FDU-PB-22(1)检测到-(萘-1-基)-1H-吲哚-3-羧酰胺2]。用1H-吲唑[AB-CHMINACA和NNEI吲唑类似物(MN-18)]新鉴定了两种合成大麻素的2H-吲唑异构体AB-CHMINACA 2H-吲唑类似物(3)和NNEI 2H-吲唑类似物(4)。 。此外,在非法产品中还检出了N-(萘-1-基)氨基甲酸2-甲基丙基酯(5)和1-戊基-1H-吲唑-3-羧酸异丁酯(6)。化合物6被认为是由化合物5和1-戊基-1H-吲唑制备NNEI吲唑类似物的副产物。新发现了苯乙胺衍生物N-OH-EDMA [N-羟基-3,4-乙撑二氧基-N-甲基苯丙胺,7]和连环酮衍生物二甲氧基-α-PHP(二甲氧基-α-吡咯烷基六苯甲酮,8)。在非法产品中。其中,化合物1和8自2014年8月和11月以来分别受到日本《药品事务法》的管制,被指定为指定物质(Shitei-Yakubutsu)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号